Viewing Study NCT03675178


Ignite Creation Date: 2025-12-18 @ 9:33 AM
Ignite Modification Date: 2025-12-23 @ 11:09 PM
Study NCT ID: NCT03675178
Status: None
Last Update Posted: 2018-09-18 00:00:00
First Post: 2018-08-05 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia
Sponsor: None
Organization:

Study Overview

Official Title: Anerning Particle for Reducing the Application of Antibiotics of Childhood Community-acquired Pneumonia: a Randomized, Double Blind, Control of Placebo, Multi-center Clinical Study
Status: None
Status Verified Date: 2018-09
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the efficacy, safety and whether it can reduction of antibiotic use in the treatment of community-acquired pneumonia in children with Anerning granules combined with ceftriaxone sodium.In this study, a randomized, double blind, parallel control of placebo, multi-center clinical study will be established. According to the relevant regulations of the CFDA, 216 cases need to be registered at least.The aim population is children who suffering of community-acquired pneumonia from September 2018 to December 2019. These cases will be devided into treatment group(Anerning particle+ Intravenous ceftriaxone sodium),control group(Anerning particle simulants+ Intravenous ceftriaxone sodium). Each group will be treated for 10 days hospitalization and if there is adverse drug reaction during treatment, follow-up until the laboratory indicators are normal. The efficacy indicators of this study were mainly from three dimensions: Frequency of antibiotics at the clinical endpoint, Total disease efficiency, Clinical recovery time. The symptom scores changes of each group before and after treatment were observed.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: